128 related articles for article (PubMed ID: 38247038)
1. Responses of the Serum Lipid Profile to Exercise and Diet Interventions in Nonalcoholic Fatty Liver Disease.
Qi Z; LE S; Cheng R; DU X; Zhao C; Zhang Z; Zhang X; Feng L; Schumann M; Mao L; Cheng S
Med Sci Sports Exerc; 2024 Jun; 56(6):1036-1045. PubMed ID: 38247038
[TBL] [Abstract][Full Text] [Related]
2. Effect of aerobic exercise and diet on liver fat in pre-diabetic patients with non-alcoholic-fatty-liver-disease: A randomized controlled trial.
Cheng S; Ge J; Zhao C; Le S; Yang Y; Ke D; Wu N; Tan X; Zhang X; Du X; Sun J; Wang R; Shi Y; Borra RJH; Parkkola R; Wiklund P; Lu D
Sci Rep; 2017 Nov; 7(1):15952. PubMed ID: 29162875
[TBL] [Abstract][Full Text] [Related]
3. Effect of aerobic exercise and low carbohydrate diet on pre-diabetic non-alcoholic fatty liver disease in postmenopausal women and middle aged men--the role of gut microbiota composition: study protocol for the AELC randomized controlled trial.
Liu WY; Lu DJ; Du XM; Sun JQ; Ge J; Wang RW; Wang R; Zou J; Xu C; Ren J; Wen XF; Liu Y; Cheng SM; Tan X; Pekkala S; Munukka E; Wiklund P; Chen YQ; Gu Q; Xia ZC; Liu JJ; Liu WB; Chen XB; Zhang YM; Li R; Borra RJ; Yao JX; Chen PJ; Cheng S
BMC Public Health; 2014 Jan; 14():48. PubMed ID: 24438438
[TBL] [Abstract][Full Text] [Related]
4. Liver Fat Scores Moderately Reflect Interventional Changes in Liver Fat Content by a Low-Fat Diet but Not by a Low-Carb Diet.
Kabisch S; Bäther S; Dambeck U; Kemper M; Gerbracht C; Honsek C; Sachno A; Pfeiffer AFH
Nutrients; 2018 Jan; 10(2):. PubMed ID: 29385034
[TBL] [Abstract][Full Text] [Related]
5. The beneficial effects of Mediterranean diet over low-fat diet may be mediated by decreasing hepatic fat content.
Gepner Y; Shelef I; Komy O; Cohen N; Schwarzfuchs D; Bril N; Rein M; Serfaty D; Kenigsbuch S; Zelicha H; Yaskolka Meir A; Tene L; Bilitzky A; Tsaban G; Chassidim Y; Sarusy B; Ceglarek U; Thiery J; Stumvoll M; Blüher M; Stampfer MJ; Rudich A; Shai I
J Hepatol; 2019 Aug; 71(2):379-388. PubMed ID: 31075323
[TBL] [Abstract][Full Text] [Related]
6. Serum lipids are associated with nonalcoholic fatty liver disease: a pilot case-control study in Mexico.
Flores YN; Amoon AT; Su B; Velazquez-Cruz R; Ramírez-Palacios P; Salmerón J; Rivera-Paredez B; Sinsheimer JS; Lusis AJ; Huertas-Vazquez A; Saab S; Glenn BA; May FP; Williams KJ; Bastani R; Bensinger SJ
Lipids Health Dis; 2021 Oct; 20(1):136. PubMed ID: 34629052
[TBL] [Abstract][Full Text] [Related]
7. Phenylmethanesulfonyl fluoride pretreatment stabilizes plasma lipidome in lipidomic and metabolomic analysis.
Wang X; Gu X; Song H; Song Q; Gao X; Lu Y; Chen H
Anal Chim Acta; 2015 Sep; 893():77-83. PubMed ID: 26398425
[TBL] [Abstract][Full Text] [Related]
8. LC-MS-based lipidomic analysis in distinguishing patients with nonalcoholic steatohepatitis from nonalcoholic fatty liver.
Wang ZH; Zheng KI; Wang XD; Qiao J; Li YY; Zhang L; Zheng MH; Wu J
Hepatobiliary Pancreat Dis Int; 2021 Oct; 20(5):452-459. PubMed ID: 34256994
[TBL] [Abstract][Full Text] [Related]
9. Effects of a carbohydrate-restricted diet on hepatic lipid content in adolescents with non-alcoholic fatty liver disease: A pilot, randomized trial.
Goss AM; Dowla S; Pendergrass M; Ashraf A; Bolding M; Morrison S; Amerson A; Soleymani T; Gower B
Pediatr Obes; 2020 Jul; 15(7):e12630. PubMed ID: 32128995
[TBL] [Abstract][Full Text] [Related]
10. Circulating branch chain amino acids and improvement in liver fat content in response to exercise interventions in NAFLD.
Shi X; Yin H; Li J; Huang C; Chen Y; Chen Z; Liu W; Weijuan Su ; Zhang Y; Lin M; Zhao Y; Li X
Sci Rep; 2021 Jun; 11(1):13415. PubMed ID: 34183740
[TBL] [Abstract][Full Text] [Related]
11. iPLA2β deficiency attenuates obesity and hepatic steatosis in ob/ob mice through hepatic fatty-acyl phospholipid remodeling.
Deng X; Wang J; Jiao L; Utaipan T; Tuma-Kellner S; Schmitz G; Liebisch G; Stremmel W; Chamulitrat W
Biochim Biophys Acta; 2016 May; 1861(5):449-61. PubMed ID: 26873633
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive assessment of hepatic lipid subspecies matched with non-alcoholic fatty liver disease phenotype.
Erickson ML; Haus JM; Malin SK; Flask CA; McCullough AJ; Kirwan JP
Nutr Metab Cardiovasc Dis; 2019 Nov; 29(11):1197-1204. PubMed ID: 31371265
[TBL] [Abstract][Full Text] [Related]
13. [A serum lipidomic study of patients with non-alcoholic fatty liver disease].
Yang RX; Hu CX; Mi YQ; Sun WL; Chen GY; Pan Q; Shen F; Xu GW; Fan JG
Zhonghua Gan Zang Bing Za Zhi; 2017 Feb; 25(2):122-127. PubMed ID: 28297799
[No Abstract] [Full Text] [Related]
14. Lipidomic Analysis of Liver and Adipose Tissue in a High-Fat Diet-Induced Non-Alcoholic Fatty Liver Disease Mice Model Reveals Alterations in Lipid Metabolism by Weight Loss and Aerobic Exercise.
Mouskeftara T; Deda O; Papadopoulos G; Chatzigeorgiou A; Gika H
Molecules; 2024 Mar; 29(7):. PubMed ID: 38611773
[TBL] [Abstract][Full Text] [Related]
15. MRI-determined liver fat correlates with risk of metabolic syndrome in patients with nonalcoholic fatty liver disease.
Chen J; Duan S; Ma J; Wang R; Chen J; Liu X; Xue L; Xie S; Yao S
Eur J Gastroenterol Hepatol; 2020 Jun; 32(6):754-761. PubMed ID: 32091437
[TBL] [Abstract][Full Text] [Related]
16. Circulating lipidomic alterations in obese and non-obese subjects with non-alcoholic fatty liver disease.
Jung Y; Lee MK; Puri P; Koo BK; Joo SK; Jang SY; Lee DH; Jung YJ; Kim BG; Lee KL; Park TS; Kang KT; Ryu DH; Kang SW; Kim D; Oh S; Kim W; Hwang GS
Aliment Pharmacol Ther; 2020 Nov; 52(10):1603-1614. PubMed ID: 32892365
[TBL] [Abstract][Full Text] [Related]
17. Effectiveness of a carbohydrate restricted diet to treat non-alcoholic fatty liver disease in adolescents with obesity: Trial design and methodology.
Dowla S; Pendergrass M; Bolding M; Gower B; Fontaine K; Ashraf A; Soleymani T; Morrison S; Goss A
Contemp Clin Trials; 2018 May; 68():95-101. PubMed ID: 29601997
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of exercise in hepatic fat mobilization in non-alcoholic fatty liver disease: Systematic review.
Golabi P; Locklear CT; Austin P; Afdhal S; Byrns M; Gerber L; Younossi ZM
World J Gastroenterol; 2016 Jul; 22(27):6318-27. PubMed ID: 27468220
[TBL] [Abstract][Full Text] [Related]
19. New botanical drug, HL tablet, reduces hepatic fat as measured by magnetic resonance spectroscopy in patients with nonalcoholic fatty liver disease: A placebo-controlled, randomized, phase II trial.
Jeong JY; Sohn JH; Baek YH; Cho YK; Kim Y; Kim H
World J Gastroenterol; 2017 Aug; 23(32):5977-5985. PubMed ID: 28932090
[TBL] [Abstract][Full Text] [Related]
20. Serum retinol binding protein 4 is associated with visceral fat in human with nonalcoholic fatty liver disease without known diabetes: a cross-sectional study.
Chang X; Yan H; Bian H; Xia M; Zhang L; Gao J; Gao X
Lipids Health Dis; 2015 Apr; 14():28. PubMed ID: 25890223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
